Back

Amiodarone induced thyroid dysfunction.

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Clinical pharmacology Antiarrhythmic Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Pall Gudjonsson

Landspitali University Hospital, Reykjavik (Iceland)

7 More presentations in this session

Presentation thumbnail
Temporal trends of first time antihypertensive treatment among citizens over 75 years - a register-based, cohort study
Mr S. Nielsen (Hellerup, DK)
Abstract Slides Video
Presentation thumbnail
Targeting liver angiotensinogen using a GalNAc-siRNA improves cardiac remodeling in spontaneously hypertensive rats
Doctor J. Wikstrom (SE)
Abstract Slides Video
Presentation thumbnail
RAAS inhibitors in patients undergoing transcatheter aortic valve implantation: insights from the EffecTAVI registry
Doctor C. Basile (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Xanthine oxidase inhibitors withdrawal syndrome
Doctor M. Kuwabara (Shimotsuke, JP)
Abstract Slides Video
Presentation thumbnail
Amiodarone and the risk for pulmonary fibrosis. A Danish nationwide study.
Doctor B. Al-Abbasi (Roskilde, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Clinical pharmacology

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Session
EHRA Consensus Paper on Antiarrhythmic Drugs (AADs)
thumbnail
Congress Presentation
Interactions of AAD with particular patient profiles, other medications and CIEDs : what is the most important to know?
thumbnail
Congress Presentation
The EHRA 'ABC' of AADs: why I still need them and what it is the updated classification?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources